Latent Tuberculosis Infection (LTBI) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Latent Tuberculosis Infection (LTBI) Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Latent Tuberculosis Infection (LTBI) Testing market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Latent Tuberculosis Infection (LTBI) Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Latent Tuberculosis Infection (LTBI) Testing market segmented into
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
- Others
- Household Contacts with Pulmonary TB
- PLHIV
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Qiagen
- BioMerieux
- Thermo Fisher Scientific
- Danaher
- Roche
- Becton Dickinson
- Agilent Technologies
- Bio-Rad Laboratories
- Eppendorf
- Abbott Laboratories
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY
2.1 Summary about Latent Tuberculosis Infection (LTBI) Testing Industry
2.2 Latent Tuberculosis Infection (LTBI) Testing Market Trends
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Production & Consumption Trends
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Demand Structure Trends
2.3 Latent Tuberculosis Infection (LTBI) Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tuberculin Skin Test (TST)
4.2.2 Interferon Gamma Released Assay (IGRA)
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Household Contacts with Pulmonary TB
4.3.2 PLHIV
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tuberculin Skin Test (TST)
5.2.2 Interferon Gamma Released Assay (IGRA)
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Household Contacts with Pulmonary TB
5.3.2 PLHIV
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tuberculin Skin Test (TST)
6.2.2 Interferon Gamma Released Assay (IGRA)
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Household Contacts with Pulmonary TB
6.3.2 PLHIV
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tuberculin Skin Test (TST)
7.2.2 Interferon Gamma Released Assay (IGRA)
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Household Contacts with Pulmonary TB
7.3.2 PLHIV
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tuberculin Skin Test (TST)
8.2.2 Interferon Gamma Released Assay (IGRA)
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Household Contacts with Pulmonary TB
8.3.2 PLHIV
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tuberculin Skin Test (TST)
9.2.2 Interferon Gamma Released Assay (IGRA)
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Household Contacts with Pulmonary TB
9.3.2 PLHIV
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Qiagen
10.1.2 BioMerieux
10.1.3 Thermo Fisher Scientific
10.1.4 Danaher
10.1.5 Roche
10.1.6 Becton Dickinson
10.1.7 Agilent Technologies
10.1.8 Bio-Rad Laboratories
10.1.9 Eppendorf
10.1.10 Abbott Laboratories
10.2 Latent Tuberculosis Infection (LTBI) Testing Sales Date of Major Players (2017-2020e)
10.2.1 Qiagen
10.2.2 BioMerieux
10.2.3 Thermo Fisher Scientific
10.2.4 Danaher
10.2.5 Roche
10.2.6 Becton Dickinson
10.2.7 Agilent Technologies
10.2.8 Bio-Rad Laboratories
10.2.9 Eppendorf
10.2.10 Abbott Laboratories
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY
2.1 Summary about Latent Tuberculosis Infection (LTBI) Testing Industry
2.2 Latent Tuberculosis Infection (LTBI) Testing Market Trends
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Production & Consumption Trends
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Demand Structure Trends
2.3 Latent Tuberculosis Infection (LTBI) Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tuberculin Skin Test (TST)
4.2.2 Interferon Gamma Released Assay (IGRA)
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Household Contacts with Pulmonary TB
4.3.2 PLHIV
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tuberculin Skin Test (TST)
5.2.2 Interferon Gamma Released Assay (IGRA)
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Household Contacts with Pulmonary TB
5.3.2 PLHIV
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tuberculin Skin Test (TST)
6.2.2 Interferon Gamma Released Assay (IGRA)
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Household Contacts with Pulmonary TB
6.3.2 PLHIV
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tuberculin Skin Test (TST)
7.2.2 Interferon Gamma Released Assay (IGRA)
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Household Contacts with Pulmonary TB
7.3.2 PLHIV
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tuberculin Skin Test (TST)
8.2.2 Interferon Gamma Released Assay (IGRA)
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Household Contacts with Pulmonary TB
8.3.2 PLHIV
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tuberculin Skin Test (TST)
9.2.2 Interferon Gamma Released Assay (IGRA)
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Household Contacts with Pulmonary TB
9.3.2 PLHIV
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Qiagen
10.1.2 BioMerieux
10.1.3 Thermo Fisher Scientific
10.1.4 Danaher
10.1.5 Roche
10.1.6 Becton Dickinson
10.1.7 Agilent Technologies
10.1.8 Bio-Rad Laboratories
10.1.9 Eppendorf
10.1.10 Abbott Laboratories
10.2 Latent Tuberculosis Infection (LTBI) Testing Sales Date of Major Players (2017-2020e)
10.2.1 Qiagen
10.2.2 BioMerieux
10.2.3 Thermo Fisher Scientific
10.2.4 Danaher
10.2.5 Roche
10.2.6 Becton Dickinson
10.2.7 Agilent Technologies
10.2.8 Bio-Rad Laboratories
10.2.9 Eppendorf
10.2.10 Abbott Laboratories
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Latent Tuberculosis Infection (LTBI) Testing Product Type Overview
2.Table Latent Tuberculosis Infection (LTBI) Testing Product Type Market Share List
3.Table Latent Tuberculosis Infection (LTBI) Testing Product Type of Major Players
4.Table Brief Introduction of Qiagen
5.Table Brief Introduction of BioMerieux
6.Table Brief Introduction of Thermo Fisher Scientific
7.Table Brief Introduction of Danaher
8.Table Brief Introduction of Roche
9.Table Brief Introduction of Becton Dickinson
10.Table Brief Introduction of Agilent Technologies
11.Table Brief Introduction of Bio-Rad Laboratories
12.Table Brief Introduction of Eppendorf
13.Table Brief Introduction of Abbott Laboratories
14.Table Products & Services of Qiagen
15.Table Products & Services of BioMerieux
16.Table Products & Services of Thermo Fisher Scientific
17.Table Products & Services of Danaher
18.Table Products & Services of Roche
19.Table Products & Services of Becton Dickinson
20.Table Products & Services of Agilent Technologies
21.Table Products & Services of Bio-Rad Laboratories
22.Table Products & Services of Eppendorf
23.Table Products & Services of Abbott Laboratories
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Latent Tuberculosis Infection (LTBI) Testing Product Type Overview
2.Table Latent Tuberculosis Infection (LTBI) Testing Product Type Market Share List
3.Table Latent Tuberculosis Infection (LTBI) Testing Product Type of Major Players
4.Table Brief Introduction of Qiagen
5.Table Brief Introduction of BioMerieux
6.Table Brief Introduction of Thermo Fisher Scientific
7.Table Brief Introduction of Danaher
8.Table Brief Introduction of Roche
9.Table Brief Introduction of Becton Dickinson
10.Table Brief Introduction of Agilent Technologies
11.Table Brief Introduction of Bio-Rad Laboratories
12.Table Brief Introduction of Eppendorf
13.Table Brief Introduction of Abbott Laboratories
14.Table Products & Services of Qiagen
15.Table Products & Services of BioMerieux
16.Table Products & Services of Thermo Fisher Scientific
17.Table Products & Services of Danaher
18.Table Products & Services of Roche
19.Table Products & Services of Becton Dickinson
20.Table Products & Services of Agilent Technologies
21.Table Products & Services of Bio-Rad Laboratories
22.Table Products & Services of Eppendorf
23.Table Products & Services of Abbott Laboratories
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Latent Tuberculosis Infection (LTBI) Testing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Latent Tuberculosis Infection (LTBI) Testin
1.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Latent Tuberculosis Infection (LTBI) Testing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Latent Tuberculosis Infection (LTBI) Testing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Tuberculin Skin Test (TST) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Interferon Gamma Released Assay (IGRA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Household Contacts with Pulmonary TB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure PLHIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Latent Tuberculosis Infection (LTBI) Testin
